Xiangxue Pharmaceutical: Report on the valuation of the total equity value assets of Beijing Xiangxue Pharmaceutical Biotechnology Co., Ltd. shareholders.

SZSI · Jul 19

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.